Metformin activates type I interferon signaling against HCV via activation of adenosine monophosphate-activated protein kinase
Wei‐Lun Tsai(Kaohsiung Veterans General Hospital), Ming‐Lung Yu(National Sun Yat-sen University)
Cited by 40
Related Papers
Treatment of chronic hepatitis C in Asia: When East meets West
|Journal of Gastroenterology and Hepatology|2009|262
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
|Metabolism|2024|111
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|Journal of the Formosan Medical Association|2020|98